Challenger appoints MS&AD rep to board
Challenger has announced the appointment of Masahiko Kobayashi as a non-executive director, following the expanded strategic relationship with MS&AD Insurance Group Holdings (MS&AD), announced in March.
As part of the relationship on 1 July, MS&AD increased its Challenger shareholding to over 15 per cent of issued capital and Challenger commenced reinsurance of US dollar-denominated annuities issued by Mitsui Sumitomo Primary Life Insurance (MS Primary), a MS&AD subsidiary.
Kobayashi would stand for re-election at Challenger’s 2019 annual general meeting, which was scheduled for 31 October 2019.
He had over 30 years’ experience in general and life insurance, and was currently director and managing executive officer (corporate planning, risk management and finance) of MS Primary.
Prior to MS Primary, Kobayashi held a number of executive and director roles within the MS&AD group, which included roles based in Singapore and the UK.
Peter Polson, Challenger chairman, said Kobayashi’s appointment built on the success of their strategic relationship with MS&AD, which commenced over three years ago.
“This relationship provides significant opportunities to expand our alliance and drive growth for both companies,” Polson said.
Recommended for you
The research house has joined this year’s awards as a research partner and will bring its experience to the awards by selecting the group award finalists.
Global research consultancy CoreData has appointed Angus Dennis from Australian Ethical Investment as it expands its research into responsible and ethical investment.
Allianz Retire+ has appointed Brendon Rodda from PIMCO as chief distribution officer for wealth management.
Following the sale of its platform business to Praemium, Iress has made a second disposal as it moves to streamline operations.